A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

Study Identifier
P15-986
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Dermatology - Psoriasis (PsO)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years

    Protocol Summary

    The objective of this non-interventional, observational study is to assess the effectiveness and patient reported outcome of adalimumab in patients with moderate to severe psoriasis in real world clinical practice in China.

    Study Locations

    Location
    Status
    Location
    The First Affiliated Hospital /ID# 171398
    Hefei, Anhui, China, 230031
    Status
    Not applicable
    Location
    Guangzhou 1st Muni People Hosp /ID# 208858
    Guangzhou, Guangdong, China, 510030
    Status
    Not applicable
    Location
    Ruijin Hospital, Shanghai Jiaotong /ID# 169833
    Shanghai, Shanghai Municipality, China, 200025
    Status
    Not applicable
    Location
    Traditional Chinese Medical Hospital of xinjiang uygur autonomous region /ID# 209183
    Ürümqi, Xinjiang, China, 830099
    Status
    Not applicable
    Location
    The Second Affiliated Hospital /ID# 169842
    Hangzhou, Zhejiang, China, 310009
    Status
    Not applicable
    Location
    Sir Run Run Shaw Hospital /ID# 169834
    Jianggan Hangzhou, Zhejiang, China, 310018
    Status
    Not applicable
    Showing {first} - {last} of {total} Results